3 Undervalued Chemicals - Commodity Stocks for Monday, September 09
Discover the top 3 undervalued Chemicals - Commodity stocks for Monday, September 09 based on AAII’s Stock Grades.Eunice Kim
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Eunice Kim
Eunice Kim
Jenna Brashear
Jenna Brashear
Grace Malone
| Share Statistics | ARKAY | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $4,669.4 | $3,682.3 | 67% |
|
| Shares Out (Mil) | 117.3 | 95.4 | 65% |
|
| Institutional Ownership | 50.0% | 79.5% | 29% |
|
| Float (Mil) | 75.6 | 118.5 | 55% |
|
| Beta | 0.96 | 0.79 | 57% |
|
| Avg Daily Volume (000s) | 1 | 157 | 4% |
|
| Price Change (52-week) |
(6.4%) | 79.1% | 47% |
|
| Growth | ARKAY | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 2.0% | 3.8% | 24% |
|
| Net Income (5yr) | (28.9%) | (0.4%) | 14% |
|
| EPS (5yr) | (34.2%) | 1.5% | 7 |
|
| Dividends (5yr) | 6.7% | 0.0% | 96% |
|
| Cash Flow (5yr) | (0.3%) | (15.4%) | 64% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | ARKAY | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $10,169 | $4,180 | 84% |
|
| Net Income (TTM) (Mil) | $68 | $70 | 57% |
|
| EPS (TTM) | $0.280 | $0.300 | 49% |
|
| Operating Cash Flow (TTM) (Mil) | $1,073 | $397 | 81% |
|
| Net Cash Flow (TTM) (Mil) | $200 | $2 | 84% |
|
| Long-Term Debt (Q1) (Mil) | $3,320 | $1,472 | 81% |
|
| Enterprise Value (Q1) (Mil) | $8,526 | $5,388 | 71% |
|
| Valuation | ARKAY | Industry Median |
Percentile (All Stocks) |
|
| P/B | na | 1.42 | na |
|
| P/E | na | 21.1 | na |
|
| Dividend Yield | na | 1.3% | na |
|
| PEG (5yr hist) | na | 1.6 | na |
|
| Ratios | ARKAY | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 17.8% | 27.6% | 18% |
|
| Net Margin | 0.7% | 3.5% | 33% |
|
| ROA | 0.4% | 1.9% | 40% |
|
| ROE | 0.8% | 4.6% | 36% |
|
| Liabilities to Assets | 50.9% | 53.6% | 43% |
|
| F-Score | na | 5 | na |
|
Arkema S.A. did not pass any screens on 10/9/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors